From fueling biomarker research and validation to enabling sensitive immunoassays, reliable native proteins allow you to elevate diagnostic science across diverse conditions.
R&D teams worldwide are using our high-purity proteins to advance diagnostics:
In recent years, Athens’ proteins have enabled investigations into biomarkers, like butyrylcholinesterase (BChE)1,3—a potential indicator of sudden infant death syndrome (SIDS) and a promising drug target for Alzheimer’s disease treatment.
With Athens, your R&D teams have a dependable foundation for assays, biosensors, calibrators, controls, and custom antibody production.
Here's how:
Our experts work closely with you to help solve complex technical problems and deliver tailored solutions that stand up to today’s clinical chemistry challenges.
See peer-reviewed studies showing how our IVD reagents advance biomarker assay and diagnostic development.